Global Oral Cancer Therapeutic Market Size, Status and Forecast 2020-2026

May 2020 | 96 pages | ID: GD077F2D4700EN
QYResearch

Abstracts

This report focuses on the global Oral Cancer Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oral Cancer Therapeutic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• AstraZeneca Plc
• Bristol-Myers Squibb Co.
• Eli Lilly and Co.
• Endo International Plc
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Mylan NV
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.

Market segment by Type, the product can be split into

• Targeted Therapy
• Chemotherapy

Market segment by Application, split into

• Floor of Mouth Cancer
• Gum Cancer
• Hard Palate Cancer
• Inner Cheek Cancer (Buccal Mucosa Cancer)
• Lip Cancer
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Oral Cancer Therapeutic status, future forecast, growth opportunity, key market and key players.
• To present the Oral Cancer Therapeutic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Oral Cancer Therapeutic are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oral Cancer Therapeutic Revenue
1.4 Market Analysis by Type
  1.4.1 Global Oral Cancer Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Targeted Therapy
  1.4.3 Chemotherapy
1.5 Market by Application
  1.5.1 Global Oral Cancer Therapeutic Market Share by Application: 2020 VS 2026
  1.5.2 Floor of Mouth Cancer
  1.5.3 Gum Cancer
  1.5.4 Hard Palate Cancer
  1.5.5 Inner Cheek Cancer (Buccal Mucosa Cancer)
  1.5.6 Lip Cancer
  1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Oral Cancer Therapeutic Market Perspective (2015-2026)
2.2 Oral Cancer Therapeutic Growth Trends by Regions
  2.2.1 Oral Cancer Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Oral Cancer Therapeutic Historic Market Share by Regions (2015-2020)
  2.2.3 Oral Cancer Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Oral Cancer Therapeutic Market Growth Strategy
  2.3.6 Primary Interviews with Key Oral Cancer Therapeutic Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Oral Cancer Therapeutic Players by Market Size
  3.1.1 Global Top Oral Cancer Therapeutic Players by Revenue (2015-2020)
  3.1.2 Global Oral Cancer Therapeutic Revenue Market Share by Players (2015-2020)
  3.1.3 Global Oral Cancer Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oral Cancer Therapeutic Market Concentration Ratio
  3.2.1 Global Oral Cancer Therapeutic Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Oral Cancer Therapeutic Revenue in 2019
3.3 Oral Cancer Therapeutic Key Players Head office and Area Served
3.4 Key Players Oral Cancer Therapeutic Product Solution and Service
3.5 Date of Enter into Oral Cancer Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Oral Cancer Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Oral Cancer Therapeutic Forecasted Market Size by Type (2021-2026)

5 ORAL CANCER THERAPEUTIC BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Oral Cancer Therapeutic Market Size by Application (2015-2020)
5.2 Global Oral Cancer Therapeutic Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Oral Cancer Therapeutic Market Size (2015-2020)
6.2 Oral Cancer Therapeutic Key Players in North America (2019-2020)
6.3 North America Oral Cancer Therapeutic Market Size by Type (2015-2020)
6.4 North America Oral Cancer Therapeutic Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Oral Cancer Therapeutic Market Size (2015-2020)
7.2 Oral Cancer Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Oral Cancer Therapeutic Market Size by Type (2015-2020)
7.4 Europe Oral Cancer Therapeutic Market Size by Application (2015-2020)

8 CHINA

8.1 China Oral Cancer Therapeutic Market Size (2015-2020)
8.2 Oral Cancer Therapeutic Key Players in China (2019-2020)
8.3 China Oral Cancer Therapeutic Market Size by Type (2015-2020)
8.4 China Oral Cancer Therapeutic Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Oral Cancer Therapeutic Market Size (2015-2020)
9.2 Oral Cancer Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Oral Cancer Therapeutic Market Size by Type (2015-2020)
9.4 Japan Oral Cancer Therapeutic Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Oral Cancer Therapeutic Market Size (2015-2020)
10.2 Oral Cancer Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Oral Cancer Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Oral Cancer Therapeutic Market Size by Application (2015-2020)

11 INDIA

11.1 India Oral Cancer Therapeutic Market Size (2015-2020)
11.2 Oral Cancer Therapeutic Key Players in India (2019-2020)
11.3 India Oral Cancer Therapeutic Market Size by Type (2015-2020)
11.4 India Oral Cancer Therapeutic Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Oral Cancer Therapeutic Market Size (2015-2020)
12.2 Oral Cancer Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Oral Cancer Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Oral Cancer Therapeutic Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AstraZeneca Plc
  13.1.1 AstraZeneca Plc Company Details
  13.1.2 AstraZeneca Plc Business Overview and Its Total Revenue
  13.1.3 AstraZeneca Plc Oral Cancer Therapeutic Introduction
  13.1.4 AstraZeneca Plc Revenue in Oral Cancer Therapeutic Business (2015-2020))
  13.1.5 AstraZeneca Plc Recent Development
13.2 Bristol-Myers Squibb Co.
  13.2.1 Bristol-Myers Squibb Co. Company Details
  13.2.2 Bristol-Myers Squibb Co. Business Overview and Its Total Revenue
  13.2.3 Bristol-Myers Squibb Co. Oral Cancer Therapeutic Introduction
  13.2.4 Bristol-Myers Squibb Co. Revenue in Oral Cancer Therapeutic Business (2015-2020)
  13.2.5 Bristol-Myers Squibb Co. Recent Development
13.3 Eli Lilly and Co.
  13.3.1 Eli Lilly and Co. Company Details
  13.3.2 Eli Lilly and Co. Business Overview and Its Total Revenue
  13.3.3 Eli Lilly and Co. Oral Cancer Therapeutic Introduction
  13.3.4 Eli Lilly and Co. Revenue in Oral Cancer Therapeutic Business (2015-2020)
  13.3.5 Eli Lilly and Co. Recent Development
13.4 Endo International Plc
  13.4.1 Endo International Plc Company Details
  13.4.2 Endo International Plc Business Overview and Its Total Revenue
  13.4.3 Endo International Plc Oral Cancer Therapeutic Introduction
  13.4.4 Endo International Plc Revenue in Oral Cancer Therapeutic Business (2015-2020)
  13.4.5 Endo International Plc Recent Development
13.5 F. Hoffmann-La Roche Ltd.
  13.5.1 F. Hoffmann-La Roche Ltd. Company Details
  13.5.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
  13.5.3 F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Introduction
  13.5.4 F. Hoffmann-La Roche Ltd. Revenue in Oral Cancer Therapeutic Business (2015-2020)
  13.5.5 F. Hoffmann-La Roche Ltd. Recent Development
13.6 Merck & Co., Inc.
  13.6.1 Merck & Co., Inc. Company Details
  13.6.2 Merck & Co., Inc. Business Overview and Its Total Revenue
  13.6.3 Merck & Co., Inc. Oral Cancer Therapeutic Introduction
  13.6.4 Merck & Co., Inc. Revenue in Oral Cancer Therapeutic Business (2015-2020)
  13.6.5 Merck & Co., Inc. Recent Development
13.7 Mylan NV
  13.7.1 Mylan NV Company Details
  13.7.2 Mylan NV Business Overview and Its Total Revenue
  13.7.3 Mylan NV Oral Cancer Therapeutic Introduction
  13.7.4 Mylan NV Revenue in Oral Cancer Therapeutic Business (2015-2020)
  13.7.5 Mylan NV Recent Development
13.8 Pfizer Inc.
  13.8.1 Pfizer Inc. Company Details
  13.8.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.8.3 Pfizer Inc. Oral Cancer Therapeutic Introduction
  13.8.4 Pfizer Inc. Revenue in Oral Cancer Therapeutic Business (2015-2020)
  13.8.5 Pfizer Inc. Recent Development
13.9 Sanofi
  13.9.1 Sanofi Company Details
  13.9.2 Sanofi Business Overview and Its Total Revenue
  13.9.3 Sanofi Oral Cancer Therapeutic Introduction
  13.9.4 Sanofi Revenue in Oral Cancer Therapeutic Business (2015-2020)
  13.9.5 Sanofi Recent Development
13.10 Teva Pharmaceutical Industries Ltd.
  13.10.1 Teva Pharmaceutical Industries Ltd. Company Details
  13.10.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
  13.10.3 Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Introduction
  13.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Oral Cancer Therapeutic Business (2015-2020)
  13.10.5 Teva Pharmaceutical Industries Ltd. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Oral Cancer Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by Oral Cancer Therapeutic Revenue
Table 3. Ranking of Global Top Oral Cancer Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oral Cancer Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Targeted Therapy
Table 6. Key Players of Chemotherapy
Table 7. Global Oral Cancer Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Oral Cancer Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Oral Cancer Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Oral Cancer Therapeutic Market Share by Regions (2015-2020)
Table 11. Global Oral Cancer Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Oral Cancer Therapeutic Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Oral Cancer Therapeutic Market Growth Strategy
Table 17. Main Points Interviewed from Key Oral Cancer Therapeutic Players
Table 18. Global Oral Cancer Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 19. Global Oral Cancer Therapeutic Market Share by Players (2015-2020)
Table 20. Global Top Oral Cancer Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Cancer Therapeutic as of 2019)
Table 21. Global Oral Cancer Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oral Cancer Therapeutic Product Solution and Service
Table 24. Date of Enter into Oral Cancer Therapeutic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 27. Global Oral Cancer Therapeutic Market Size Share by Type (2015-2020)
Table 28. Global Oral Cancer Therapeutic Revenue Market Share by Type (2021-2026)
Table 29. Global Oral Cancer Therapeutic Market Size Share by Application (2015-2020)
Table 30. Global Oral Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 31. Global Oral Cancer Therapeutic Market Size Share by Application (2021-2026)
Table 32. North America Key Players Oral Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Oral Cancer Therapeutic Market Share (2019-2020)
Table 34. North America Oral Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 35. North America Oral Cancer Therapeutic Market Share by Type (2015-2020)
Table 36. North America Oral Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 37. North America Oral Cancer Therapeutic Market Share by Application (2015-2020)
Table 38. Europe Key Players Oral Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Oral Cancer Therapeutic Market Share (2019-2020)
Table 40. Europe Oral Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Oral Cancer Therapeutic Market Share by Type (2015-2020)
Table 42. Europe Oral Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Oral Cancer Therapeutic Market Share by Application (2015-2020)
Table 44. China Key Players Oral Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 45. China Key Players Oral Cancer Therapeutic Market Share (2019-2020)
Table 46. China Oral Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 47. China Oral Cancer Therapeutic Market Share by Type (2015-2020)
Table 48. China Oral Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 49. China Oral Cancer Therapeutic Market Share by Application (2015-2020)
Table 50. Japan Key Players Oral Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Oral Cancer Therapeutic Market Share (2019-2020)
Table 52. Japan Oral Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Oral Cancer Therapeutic Market Share by Type (2015-2020)
Table 54. Japan Oral Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Oral Cancer Therapeutic Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Oral Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Oral Cancer Therapeutic Market Share (2019-2020)
Table 58. Southeast Asia Oral Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Oral Cancer Therapeutic Market Share by Type (2015-2020)
Table 60. Southeast Asia Oral Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Oral Cancer Therapeutic Market Share by Application (2015-2020)
Table 62. India Key Players Oral Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 63. India Key Players Oral Cancer Therapeutic Market Share (2019-2020)
Table 64. India Oral Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 65. India Oral Cancer Therapeutic Market Share by Type (2015-2020)
Table 66. India Oral Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 67. India Oral Cancer Therapeutic Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Oral Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Oral Cancer Therapeutic Market Share (2019-2020)
Table 70. Central & South America Oral Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Oral Cancer Therapeutic Market Share by Type (2015-2020)
Table 72. Central & South America Oral Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Oral Cancer Therapeutic Market Share by Application (2015-2020)
Table 74. AstraZeneca Plc Company Details
Table 75. AstraZeneca Plc Business Overview
Table 76. AstraZeneca Plc Product
Table 77. AstraZeneca Plc Revenue in Oral Cancer Therapeutic Business (2015-2020) (Million US$)
Table 78. AstraZeneca Plc Recent Development
Table 79. Bristol-Myers Squibb Co. Company Details
Table 80. Bristol-Myers Squibb Co. Business Overview
Table 81. Bristol-Myers Squibb Co. Product
Table 82. Bristol-Myers Squibb Co. Revenue in Oral Cancer Therapeutic Business (2015-2020) (Million US$)
Table 83. Bristol-Myers Squibb Co. Recent Development
Table 84. Eli Lilly and Co. Company Details
Table 85. Eli Lilly and Co. Business Overview
Table 86. Eli Lilly and Co. Product
Table 87. Eli Lilly and Co. Revenue in Oral Cancer Therapeutic Business (2015-2020) (Million US$)
Table 88. Eli Lilly and Co. Recent Development
Table 89. Endo International Plc Company Details
Table 90. Endo International Plc Business Overview
Table 91. Endo International Plc Product
Table 92. Endo International Plc Revenue in Oral Cancer Therapeutic Business (2015-2020) (Million US$)
Table 93. Endo International Plc Recent Development
Table 94. F. Hoffmann-La Roche Ltd. Company Details
Table 95. F. Hoffmann-La Roche Ltd. Business Overview
Table 96. F. Hoffmann-La Roche Ltd. Product
Table 97. F. Hoffmann-La Roche Ltd. Revenue in Oral Cancer Therapeutic Business (2015-2020) (Million US$)
Table 98. F. Hoffmann-La Roche Ltd. Recent Development
Table 99. Merck & Co., Inc. Company Details
Table 100. Merck & Co., Inc. Business Overview
Table 101. Merck & Co., Inc. Product
Table 102. Merck & Co., Inc. Revenue in Oral Cancer Therapeutic Business (2015-2020) (Million US$)
Table 103. Merck & Co., Inc. Recent Development
Table 104. Mylan NV Company Details
Table 105. Mylan NV Business Overview
Table 106. Mylan NV Product
Table 107. Mylan NV Revenue in Oral Cancer Therapeutic Business (2015-2020) (Million US$)
Table 108. Mylan NV Recent Development
Table 109. Pfizer Inc. Business Overview
Table 110. Pfizer Inc. Product
Table 111. Pfizer Inc. Company Details
Table 112. Pfizer Inc. Revenue in Oral Cancer Therapeutic Business (2015-2020) (Million US$)
Table 113. Pfizer Inc. Recent Development
Table 114. Sanofi Company Details
Table 115. Sanofi Business Overview
Table 116. Sanofi Product
Table 117. Sanofi Revenue in Oral Cancer Therapeutic Business (2015-2020) (Million US$)
Table 118. Sanofi Recent Development
Table 119. Teva Pharmaceutical Industries Ltd. Company Details
Table 120. Teva Pharmaceutical Industries Ltd. Business Overview
Table 121. Teva Pharmaceutical Industries Ltd. Product
Table 122. Teva Pharmaceutical Industries Ltd. Revenue in Oral Cancer Therapeutic Business (2015-2020) (Million US$)
Table 123. Teva Pharmaceutical Industries Ltd. Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Oral Cancer Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Targeted Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Global Oral Cancer Therapeutic Market Share by Application: 2020 VS 2026
Figure 5. Floor of Mouth Cancer Case Studies
Figure 6. Gum Cancer Case Studies
Figure 7. Hard Palate Cancer Case Studies
Figure 8. Inner Cheek Cancer (Buccal Mucosa Cancer) Case Studies
Figure 9. Lip Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Oral Cancer Therapeutic Report Years Considered
Figure 12. Global Oral Cancer Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Oral Cancer Therapeutic Market Share by Regions: 2020 VS 2026
Figure 14. Global Oral Cancer Therapeutic Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Oral Cancer Therapeutic Market Share by Players in 2019
Figure 17. Global Top Oral Cancer Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Cancer Therapeutic as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Oral Cancer Therapeutic Revenue in 2019
Figure 19. North America Oral Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Oral Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Oral Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Oral Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Oral Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Oral Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Oral Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. AstraZeneca Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. AstraZeneca Plc Revenue Growth Rate in Oral Cancer Therapeutic Business (2015-2020)
Figure 28. Bristol-Myers Squibb Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bristol-Myers Squibb Co. Revenue Growth Rate in Oral Cancer Therapeutic Business (2015-2020)
Figure 30. Eli Lilly and Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Eli Lilly and Co. Revenue Growth Rate in Oral Cancer Therapeutic Business (2015-2020)
Figure 32. Endo International Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Endo International Plc Revenue Growth Rate in Oral Cancer Therapeutic Business (2015-2020)
Figure 34. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Oral Cancer Therapeutic Business (2015-2020)
Figure 36. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Merck & Co., Inc. Revenue Growth Rate in Oral Cancer Therapeutic Business (2015-2020)
Figure 38. Mylan NV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Mylan NV Revenue Growth Rate in Oral Cancer Therapeutic Business (2015-2020)
Figure 40. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Pfizer Inc. Revenue Growth Rate in Oral Cancer Therapeutic Business (2015-2020)
Figure 42. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Sanofi Revenue Growth Rate in Oral Cancer Therapeutic Business (2015-2020)
Figure 44. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Oral Cancer Therapeutic Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation